Skip to content

Drug interactions

Aprepitant + Ceritinib

Severity: Moderate

Aprepitant and Ceritinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ceritinib inhibits CYP3A4 and may raise aprepitant concentrations. Higher aprepitant exposure could increase adverse effects such as fatigue, dizziness and gastrointestinal upset.

What this interaction means in plain words

Aprepitant and Ceritinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Aprepitant belongs to Gastrointestinal Tract; Ceritinib belongs to Oncology.

Evidence level: Low

Why it happens

Ceritinib inhibits CYP3A4, reducing the metabolic clearance of aprepitant, which is a CYP3A4 substrate.

What to do

Monitor for aprepitant adverse effects during co-use. Ceritinib is also a CYP3A4 substrate, so watch for ceritinib toxicity because aprepitant is a moderate CYP3A4 inhibitor.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Ceritinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Ceritinib?

MediHelp rates the interaction as moderate. Aprepitant and Ceritinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ceritinib inhibits CYP3A4 and may raise aprepitant concentrations. Higher aprepitant exposure could increase adverse effects such as fatigue, dizziness and gastrointestinal upset.

How serious is the interaction between Aprepitant and Ceritinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for aprepitant adverse effects during co-use. Ceritinib is also a CYP3A4 substrate, so watch for ceritinib toxicity because aprepitant is a moderate CYP3A4 inhibitor.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in